【衝撃】日本の透析患者34万人、半年後に全員死亡か・・・・
A sensational headline, "Will all 340,000 dialysis patients in Japan die in six months?" has gone viral online, though it's largely an exaggeration. The real issues behind it are the escalating burden of dialysis treatment on Japan's healthcare costs and the future of its medical system amidst an aging population. Online reactions range from disbelief at the overstatement to serious discussions about the gravity of healthcare financial challenges.
Related Keywords
Artificial Dialysis and its Current State
Artificial dialysis is a medical procedure that uses a machine to purify blood for patients whose kidney function has significantly deteriorated, making them unable to adequately excrete waste products and excess water from their bodies. In Japan, common causes include diabetic nephropathy, chronic glomerulonephritis, and nephrosclerosis. As of the end of 2022, approximately 348,000 people are undergoing dialysis treatment, a remarkably high figure globally. There are mainly two types: hemodialysis performed in hospitals and peritoneal dialysis performed at home. Once initiated, treatment typically requires multiple sessions per week, lasting several hours each, for the rest of a patient's life, significantly impacting their daily routine. Japanese dialysis care is supported by advanced technology and dedicated medical professionals, leading to relatively good prognoses for patients, but its maintenance incurs substantial medical costs. The specific number "340,000 dialysis patients in Japan" highlights the magnitude of this patient population, and understanding the sustainability of the medical system supporting them, along with the treatments they receive, is crucial for grasping the underlying sense of crisis in the article.
National Medical Expenses and Healthcare Cost Optimization
National medical expenses refer to the total cost of medical care paid when citizens receive treatment for illness or injury. Japan's national medical expenses reached approximately 43 trillion yen in fiscal year 2021 and are increasing annually due to the aging population and advancements in medical technology. Japan boasts an excellent universal healthcare system that allows everyone to receive high-quality medical care at relatively low costs, but the financial burden of maintaining this system is enormous. In particular, artificial dialysis is extremely expensive, costing around 5 million yen per patient annually, and accounts for a significant portion of the total national medical expenditure. To address this, the government has formulated "Healthcare Cost Optimization Plans" aimed at curbing the growth of medical expenses through measures such as improving medical efficiency, promoting preventive medicine, and encouraging the use of generic drugs. However, reducing medical costs is a highly delicate issue as it directly affects patients' lives and health. The extreme expression "Will all die?" in the article's title is understood as a metaphorical warning about the severe financial strain on the medical system, especially the soaring costs of dialysis, suggesting a crisis in medical finance that could potentially lead to the collapse of Japan's healthcare system.
End-of-Life Care and Advance Care Planning (ACP)
End-of-life care refers to medical treatment provided to patients whose condition has progressed with no hope of recovery. It is fundamentally based on the idea that the patient's wishes should be respected regarding whether to continue life-sustaining treatment, prioritize pain relief, or how to spend their final days. Artificial dialysis can also be a consideration in end-of-life care, especially for elderly patients with multiple underlying conditions. Since dialysis generally cannot be stopped once initiated, the decision to start it or for a patient to choose to discontinue it is a profoundly complex issue deeply intertwined with medical ethics and the patient's Quality of Life (QOL). Here, "Advance Care Planning (ACP)," commonly known as "Jinsei Kaigi" (Life Conference), becomes crucial. This refers to a process where patients repeatedly discuss their future medical care and treatment with their families and healthcare professionals to share their wishes. The extreme question posed by the article's title, "Will all die?" may not only concern healthcare costs but also suggest a more fundamental inquiry into end-of-life care, such as the dignity of individual lives, choices regarding life-sustaining treatment, and the formation of societal consensus to support such choices, amidst a strained medical system.